Jupiter Life Line Hospitals Ltd (NSE: JLHL) Q3 2026 Earnings Call dated Feb. 02, 2026
Corporate Participants:
Ankit Thakker — Joint Managing Director and Chief Executive Officer
Analysts:
Unidentified Participant
Manav Jain — Analyst
Kritika Damani — Analyst
Himanshu Binani — Analyst
Kaustav Bubna — Analyst
Amit Thawani — Analyst
Ashutosh Nemani — Analyst
Presentation:
operator
Ladies and Gentlemen, good day and welcome to Jupiter Life Lion Hospital Limited Q3 and 9M FY26 earnings conference call. This conference call may contain forward looking statements about the company which are based on the beliefs, opinions and expectations of the company as on date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict. As a reminder, all participant lines will be in the listen only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing Star then zero on your touchstone phone.
Please note that this conference is being recorded. I now hand the conference over to Dr. Ankit Thakkar, Joint Managing Director and CEO. Thank you and over to you Mr. Thakar.
Ankit Thakker — Joint Managing Director and Chief Executive Officer
Good morning everyone. Thank you for joining us on our earnings call to discuss the business and financial performance for Q3 and 9 months of FY26. I hope you had an opportunity to review our results and investor presentation which have been uploaded on the website and the stock exchanges. I am joined today by Mr. Shivasi Sen, our CFO, Ms. Suma Upadhy, our Company Secretary and Compliance Officer and our Investor Relations Advisors sga. I am delighted to kick off this. Monday morning call with a good news. Our hospital in Dombiwali is ready to be launched. The 750,000 square foot 500 bed structure has been completed before time and on budget ahead of its planned launch in Q1 of FY27. This was a phenomenal project execution effort wherein we were able to complete the entire construction for the 500 beds, fit outs for over 300 beds and all biomedical equipment installation in just over 24 months and at a capex of roughly 425 crores. I want to take a moment here to thank all our partners in this project beginning from the consultants, contractors, vendors, our own project team and also the regulatory authorities all of whom went above and beyond to enable us to deliver this project.
We also welcome all the doctors and the team members who have already come on board to join us in our mission to deliver the kind of healthcare to the region around Dombeivali that the community has come to expect from Jupiter over the last two decades. The hospital is slated to be inaugurated on February 15 and will commence full clinical operations thereafter. In the interest of operational efficiency, we will only begin operating 200 beds in phase one and then ramp up capacity in a phased manner as the occupancy increases. A heads up for everyone on this call though that beginning next quarter you will see a much higher depreciation load than you have seen so far and should also expect an EBITDA drag on the consolidated numbers for around the next two years before the new hospital can start contributing financially.
The Pune south project construction has kicked off and is progressing well and the Mira Road project is under regulatory approval process. Alongside this expansion, our existing hospitals continue to demonstrate steady operating momentum with no surprises or specific highlights to report other than the impact of the new Labour Code. Our PBT in this quarter is therefore impacted to the tune of 6.4 crores due to this exceptional one time provision. I will give you the highlights of our consolidated financial performance now. The numbers for Q3 of this financial year. Total income stood at 365.3 crores in this quarter, an increase of 9.8%.
Year on year. EBITDA stood at 83.4 crores, an increase of 9.2%. Year on year the EBITDA margin is 22.8%. In this quarter the PAT stood at 42.5 crores representing a decrease of 18.7% year on year and the margin for the quarter is 11.6%. The nine month numbers total income is. 1111.9 crores an increase of 15.1% year on year. The EBITDA is 254 crores an increase of 15.2% year on year. The Ebitda margin is 22.8% for the nine month period. The PAT is 143.9 crores for the nine month period a decrease of 3.1% year on year. As highlighted earlier, the PAT is impacted. Due to the new Labor Code changes and the margin is 12.9%. The RPOP for the nine month period is 66,800. The ALOSS is 3.85 days and the average occupancy for nine months is 61.9%. The payer makes insurance represents 55.7%, self payers 43.2% and government schemes at just around 1.1%. With this I conclude my opening remarks and open the floor for questions and answers. Thank you.
Questions and Answers:
operator
Thank you. We will now begin the question and answer section. Anyone who wishes to ask a question may press star and one on a touchstone telephone. If you wish to remove yourself from the question queue, you may press star and 2. Participants are requested to use handsets while asking a question. Ladies and gentlemen, we will wait for a moment while the question queue assembles. Once again, a reminder to all the participants that you may press star and one to ask a question. The first question comes from the line of Manav Jain from Jain Investments. Please go ahead.
Manav Jain
Hi sir, good morning. Congratulations on the opening of the new hospital. My question is regarding the Pune Bbwadi project. Could you please share an update on. The current state of the construction and the total capex incur till date for the hospital?
Ankit Thakker
Good morning Manav. Thank you. So the Bbywadi project is as I said construction has begun. We have just started the basement work so it is in early stages of construction. The excavation is now over as we have said that we are slated to begin it sometime in calendar year 28 and we are reasonably sure to achieve. This that target capex so far as. You can imagine because it’s only excavation and little bit of basement is not very high but maybe less than 50 crores so far.
Manav Jain
Okay sir and you could you please share the total capex incurred during 9 months FY26 and also provide hospital wise. Capex for Dombeulet and Pune facilities.
Ankit Thakker
So Dombioli as I said 425 crores. Is the total that we have spent for the project Pune I can see a number of around 45 crores so far neither road we have not started.
Manav Jain
Okay sir. Yes that was very helpful. Thank you.
Ankit Thakker
Thank you.
operator
Thank you. Next question comes on the line of Ashitosh Lemani with GM Financial.
Unidentified Participant
Yeah hello. Am I audible?
Ankit Thakker
Yes Ashutosh, go ahead.
Unidentified Participant
My first question is regarding the ramp up plan of Dumballi hospital. So how do you anticipate occupancy ramp up? If you can guide let’s say for the next three to four quarters and how do the specialty mix and what is the expected of the.
Ankit Thakker
So as I’ve said, you know you have to look at it in a longer term. The first three year period we consider as a stabilization, foundational or maturity kind of period and the next three year period we consider as a rapid growth period. So these are long term infrastructure kind of community assets and we don’t really look at it quarter to quarter for the first couple of years. How exactly it will ramp up remains to be seen but typically for all the projects that we have done we consider two to three years as an establishment period.
The specialty mix will be identical to all other hospitals. We will offer all services here beginning from childbirth to transplantation. As I said the revenues should be in line with the Mumbai region Thane hospital that we have. The RPOB of course is also representative of the case mix so initially when a hospital is started it has relatively lesser load of complex services or tertiary quaternary work and more load of primary secondary work. So as the hospital gains maturity the RPOB should converge. But in the earlier periods rpobs will look smaller than the thana hospitals.
Unidentified Participant
Okay, and what is the timeline for breakeven of this hospital? And did that drag for the first two to three years?
Ankit Thakker
By end of year two we expect. To be EBITDA breakeven.
Unidentified Participant
And the third question is, could you tell us the RFOB of Q3? 26 on console basis?
Ankit Thakker
26 on console basis is 68,000.
Unidentified Participant
8,000 and occupancy?
Ankit Thakker
Occupancy is 61.4%.
Unidentified Participant
Thanks a lot.
operator
Thank you. The next question comes from the line of Kritika Damani with Prospera Financial Solutions. Please go ahead.
Kritika Damani
Yes, hello. Congratulations on a strong quarter. I want to know despite the sustained EBITDA margins, depreciation and finance cost have been rising due to recent and ongoing capex. How does it, how should we think about the margin trajectory over the next few quarters as the new assets start contributing? But the costs are already in the P and L.
Ankit Thakker
So Kritika on the three operating hospitals, two are near maturity so they should have similar margins. Indore is in its growth phase. We should expect slightly incremental margins from Indore over the next couple of years. And Domviwali, as I just said a short while back, should lose money for the first year or two. So there will be a little bit of drag on the console numbers on account of Dombeivali for the next couple of years.
Kritika Damani
And my second question is with the multiple Greenfield hospital under development alongside the Metro Hospital running, what internal metrics do you monitor most closely to ensure growth does not begin to dilute operational control or the clinical outcomes?
Ankit Thakker
So both are completely independent teams. The project team has very little or nothing to do with operations and the clinical operating team. The medical teams have absolutely nothing to do with the new projects going on. So both of them have their separate roles cut out very clearly and you know, new green fields coming up have zero impact on our clinical performance or operational performance.
Kritika Damani
All right, thank you. I’ll get back to the.
Ankit Thakker
Thank you.
operator
Thank you. Next question comes to the line of Himanshu Binani with Anandrati. Please go ahead.
Himanshu Binani
Thank you sir for taking my question. So sir, I have one question basically regarding to the now the European trade deal is like largely done. So what we are seeing is that there has been like an absolute decrease in the import Duties of medical equipments. So how one should actually look into the CAPEX numbers going forward? As in what is your initial understanding in terms of the capex which can like be reduced or there is like any sort of like saving into the CAPEX numbers for you as well as for the industry?
Ankit Thakker
I have two understandings. One is that headlines are different and fine prints and implementation is different. So I would wait to see how it gets implemented and what is in the fine print. And the other thing, just to set context also for everybody’s benefit is that even though a lot of companies are headquartered today in Europe and the US a lot of them have manufacturing facilities in China. So the country of export becomes China and the deal with Europe, I don’t know how much it would have in machines being shipped out of China.
Himanshu Binani
Okay, got it. And second question is on the Dhumivali project, so what would be the initial like the EBITDA drag from that hospital for the first two years?
Ankit Thakker
So remains to be seen in the past, as I have said that our. Previous hospital experiences first year something between 2 to 3 crores a month should be the average for the first year. But let us see how this shifts.
Himanshu Binani
Sure sir. Thank you.
Ankit Thakker
Thank you.
operator
Thank you. A reminder to all the participants setting up a star and one to ask a question. Next question comes from the line of cost of opener with BMSP in capital.
Kaustav Bubna
Yeah, hi, thanks for taking my question. So I basically wanted to understand for all the hospitals you have, What is your real, what’s your strategy when you find land to create a new hospital? Are these hospitals in areas where you have no competition around you? And then if that’s the case, how do you get good doctors and with faculty if these hospitals are not in, you know, how would I say it, in common areas where accessible to. Easily accessible to good faculty and doctors.
Ankit Thakker
Yes. So first of the metric for selection. Of locations is multifold. A. We are currently only looking at large cities in western India. Typically in, you know, when you are in a large city it is also proxy for HR and availability of manpower, including doctors. But within the large cities we do look for those specific micro markets where the resident population is very high and in the near vicinity there would be a relatively low supply of high end tertiary care services. This does not mean that there are no other hospitals because all large cities have cover, but it means that they are predominantly supplied by Tier 2 hospitals.
The other thing which I must highlight is that the tier 2 hospital is tier 2 because of infrastructure and not necessarily because of manpower. Lot of these doctors in big cities, they are all trained similarly to for example doctors in Dombioli. And doctors in South Bombay would be classmates in same medical school. For example, they may be from JJ or KM or whatever, but just based on where they live and work, the quality of infrastructure and technology available to them may not be commensurate with their qualifications and they make do with what they have. So when we enter these micro markets, it becomes a natural choice for a lot of these skilled medical practitioners to want to affiliate and associate with us and it becomes a win win symbiotic kind of association.
So I hope that gives you some color and understanding on what we are doing and how.
Kaustav Bubna
So is this the same strategy for your Pune hospitals too? The one that’s coming up? Is this the same strategy across every single hospital that you’re so far. Again, yes. Okay. Okay. And, and I wanted to understand three years or five years down the line, what is our RPOC target? I mean are we looking to with is there some level of, you know, offerings which have higher average revenue per bed which the hospital currently does not undertake? I mean this could. Could you strategically give some indication on will RPOX remain at similar levels or are we trying to increase higher RPOC offerings?
Ankit Thakker
So I’ll answer the second question first. There is no service that we don’t offer currently. We practice all branches of medicine and offer critical tertiary quaternary level services. All branches of medicine. We do not have any RPOP targets either now nor for the future. We think that this RPOP number is more of a byproduct of what you do. We are not looking at or chasing any specific RPOP number. We will continue to provide all all services in all the hospitals because that aligns with our operating and clinical philosophy. We don’t want to have narrowly focused hospitals. We want to have broad spectrum full service hospitals. And irrespective of which branch generates how much rpob, honestly we don’t track it internally also.
So yeah, whatever happens happens Generally in the initial phases of operations, as I was saying earlier, the rpobs are lower because you do more of primary secondary work. But as the hospital matures, the RPOB also reaches maturity after which it only grows in line with inflation. So that would be my broad guidance to you that the mature asset r Bob’s should grow in line with inflation and the newer hospitals should grow a little faster in the earlier phases and once they mature, they should grow in line with inflation. But no, there is no target.
Kaustav Bubna
Okay, great. Thank You I’ll join back with you.
Ankit Thakker
Thank you Kauster.
operator
Thank you. A reminder to all the participants that you have a star and one two Ask a question. Next question comes from the line of Amit Tawani with Clear Blue Capital. Please go ahead.
Amit Thawani
Hi. Thank you for taking my question. I think this is the first quarter we’ve reported a single digit top line growth. Can you explain what has happened this quarter?
Ankit Thakker
Nothing has happened. Thank you for bringing it to my notice. I had not noticed that but as I again couple of questions back said that healthcare cannot be done monitored on quarter to quarter. Also each hospital has finite capacity. Very soon I would hope that all the mature hospitals are able to report zero growth because they are already at maturity. So the growth eventually comes from new and upcoming hospitals where. You know you. Start from zero now does not really have too much ability to generate more occupancy growth. Puna the opportunity is narrowing. Indore still definitely has opportunity for higher growth and we hope to see that play out over the next couple of years.
Amit Thawani
But anything, any, any issue on the payers side? I mean we had some problem with insurer companies as an industry. I’m not sure what that problem, how severe that problem was with Jupiter.
Ankit Thakker
No, we have not had any serious problem with the payer companies. We have had largely uninterrupted services for almost all payers. We also have not had any unusual friction with the peer community. So I would not attribute anything to friction with the payers.
Amit Thawani
Do you see any takeaways for us from the new EU India trade deal on medical tourism?
Ankit Thakker
I. I have not caught if there is any impact on medical tourism per se for the EU deal. I’m not sure if there is but I will look it up on the import duty side as the question sometime back if, if it does play out the way it is publicized especially those exp equipment being shipped out of Europe hopefully should get cheaper and that should to some extent at least help us counter the depreciating rupees. So that might be welcome.
Amit Thawani
Got it. My last question, Sorry I think I might have missed the answer for this. Can you tell me what the yoyo y growth in RPOB is And yeah if you can just break up the revenue growth into a loss RPOB.
Ankit Thakker
Alos I don’t have. What I have is last year alos was for nine months 3.88. This point in time it is 3.85. So largely similar RPOB was 59,000 plus something and this time it is 66,000.
Amit Thawani
So almost entire 9% quad growth, 10% growth this quarter is from RPOB.
Ankit Thakker
Yeah.
Amit Thawani
Thank you. Thank you.
Ankit Thakker
Thank you.
operator
Thank you. Next question comes from the line of Aryaman with prudent im. Please go ahead.
Unidentified Participant
Yeah. Hi sir, just one question from my side. So what could be the same respectable cvss, bright height. So what should be? Could you benefit from this? And what’s the timeline if you benefit at all?
Ankit Thakker
So your voice is muffled but I. What I heard is you were asking about cghs, is that correct?
Unidentified Participant
Yes. Cgh, the price.
Ankit Thakker
Yeah. So we currently don’t have any CGHS exposure on our pnl. So as we stand today, it does not impact us. But I understand that the CGHS rates are revised after a period of 10 years and there is a substantial hike that the government has offered this time. But as far as Jupiter is concerned, you will not see any impact on that account.
Unidentified Participant
Sure. Thank you sir.
operator
Thank you. Next question comes from the line off Jjain JJ investments. Please go ahead.
Unidentified Participant
Hello. Hi sir. So just one question from my side. Last year we added 78 beds at indoor hospital. How is the hospital’s overall performance since commissioning of those beds particularly in terms of occupancy, ramp up and RPOP growth? If you can just highlight us.
Ankit Thakker
Yes, you are right. We added about 78 beds last year. We have on absolute, of course, because of a larger base, the percentage occupancy is lower in Indore. But on an absolute term I’m happy to confirm to you that the occupancy this year is higher than what it was last year and that these 78 beds have started getting utilized and are being put to use the RPOP site we should have had a growth of, let me see, maybe 15 odd percent. I think on account of both inflation and this maturity phase. As I was saying, you will see higher RPOB growth in the first six odd years until it reaches maturity, after which it only grows in line with inflation.
Inflation. So Indo Rar pop for the next couple of years should grow a little faster than inflation, logically. And that is what we are also seeing play out.
Unidentified Participant
Okay, thank you, that was helpful.
Ankit Thakker
Thank you.
operator
Thank you. Next question comes from the line of Rishi Kapoor with fil. Please go ahead.
Unidentified Participant
Yeah, thank you for taking my questions. My question is regarding the demand supply situation. So just want to have the general view. You brought a view regarding this. So how is the demand supply situation evolving across the Thane, Pune and Indore given the rising occupancies and the ongoing capacity additions?
Ankit Thakker
So in the Current three locations, it is pretty much status quo. The population keeps increasing, the insurance penetration keeps increasing. Large Indian cities. So on account of both those factors, the demand is still very high. I don’t think the supply situation is enough in either of the three markets at a high quality. And I think that high quality supply will very easily get absorbed in Thana, Pune, Indore, even if Mall were to come from where we stand today.
Unidentified Participant
All right, and regarding specifically about the RPAP growth and that you talked about the new hospital that is coming but on the consolidated basis, any view on the ARPA growth outlook for the next 1, 2, 3 years?
Ankit Thakker
I don’t know how it will really play out because there will be some drag from Dombeli and some, you know, positive from the other three on a account of inflation and higher growth of Indore. So in a blended level, how it will play out, I have not really done too much modeling around it. But Domioli will be diluting. Indore will be a little higher than inflation. Tanakuna will be inflation linked growth.
Unidentified Participant
All right, thank you.
Ankit Thakker
Thank you.
operator
Thank you. Next question comes from the line of Ashutosh Nemani with GM Financial Family Office. Please go ahead.
Ashutosh Nemani
Thanks for the opportunity. My first question is with so much bed addition to the next two years, there have been some concerns highlighted by the peers regarding availability of star doctors and specifically nurses also. So how do you foresee that? Do you see Dr. Cost driving substantially when all this capacity comes up in the industry?
Ankit Thakker
So nurses is a national challenge and there is nothing new. It has been a challenge for a long time. Not specific to one hospital or one location. There is no magic answer to it. I think it will continue to remain a challenge on the doctor side. My view is that if you are in large city then you don’t have too much of a problem. As you start going into smaller and smaller tier three and those kind of locations then the availability of doctors is much lower. And interestingly the Dr. Cost in smaller cities is much higher than Dr.
Cost in larger cities. But in the locations that we operate it is not hard to find good doctors.
Ashutosh Nemani
Could you just like quantitatively tell us what, what is Dr. Cost as a percentage of revenue and how has it evolved in the past two to three years?
Ankit Thakker
So I don’t have quantitative numbers but typically the doctor cost varies between 20 and 25% of the top line. So. And we have generally been in that range.
Ashutosh Nemani
Okay. And the second question is regarding thane operations with peer adding multi specialty hospital. Any occupancy, any impact on Occupancy level and senior doctor attrition.
Ankit Thakker
About Thane.
Ashutosh Nemani
One of the, one of the peers has also added a hospital in that region. So any impact on Dr. Attrition? You are seeing.
Ankit Thakker
No impact on Dr. Attrition. We have had one full time Dr. Move but so I would call it zero attrition.
Ashutosh Nemani
Okay, yeah, thanks a lot.
operator
Thank you. A reminder to all the participants that you may press star and one to ask a question. Next question comes from the line of cost of Bubna with BMSPL capital. Please go ahead.
Kaustav Bubna
Hi, I just had a few more questions. So you know, in previous interviews it was mentioned that you may think about adding a seventh hospital. So do you have any updates on that in terms of how you were thinking of where that you know, how do you, where do you think is a good location for your seventh hospital? How are you thinking about that? If so, and I think I have a broader vision question also along with that is, I mean what, how do you see, what is your strategy really in terms of capex play growth over the next decade? Taking into situation obviously taking into understanding your perception of demand supply over the next decade.
So if you could answer those questions.
Ankit Thakker
So I’m happy to get a question about a decade and not a quarter. I like longer term thinking than quarterly thinking, especially for health care. You know, as the demand supply stands today, even now as we speak, there is a huge mismatch at a national level. Even at prominent high tier 1 metro city levels, I think we still have a lot more supply to create than what we need. We have to replace some of the old secondary care nursing homes with respectable health care operators because nowhere else in the world is healthcare provided in 15, 20, 30 better nursing homes as it is provided in Mumbai and other cities of India.
So on the supply side, I am absolutely convinced that there is more needed than what the whole industry collectively will be able to deliver. The players today will be collectively able to deliver over the next decade. So I think the growth story on Indian healthcare is probably longer than a decade. There is just too much to be done. And along with that, as the time goes on, more and more cities progress. They become larger and they become centers which will be able to absorb large hospitals because of rising population, rising income levels and higher insurance penetration.
So at an industry level, I think it is a multi decade story. It is not a yearly or certainly not quarterly story. As far as Jupiter is concerned. You are right in your observation. We are keen to do the seventh hospital as well. We remain committed to western India for now we are in discussions with few opportunities currently, but I don’t have any announcement to make about where that location will be and when it will really mature because we are keen to do a green field and land being land with all its uncertainties in India you can’t really, you know, go out and make predictions before you deliver.
Kaustav Bubna
So. As a company you, over the next decade you plan to participate in the supply growth. You will not. It’s not like oh, I want to stay at eight hospitals, seven hospitals and then let the supply grow as we won’t do anymore. You plan to grow with the supply growth, Is that, is that a correct understanding?
Ankit Thakker
There is nothing else I know how to do, so we’ll have to keep doing this.
Kaustav Bubna
Okay, and just one last question on the doctor aspect. I know it’s just, it’s an ongoing struggle, it’s just part of the industry. But you know, so also please if you could help my understanding better because this question comes out of a little bit of lack of understanding and knowledge about exactly how this works and how it is currently. But let’s take Reliance Hospital for example in Lokhandwala in Mumbai. I know that that hospital offers now tells doctors that listen exclusively and obviously that would and they apparently provide a very nice package to doctors which disincentivizes doctors to even go and look for other opportunities to say that we’ll compensate you well enough to be with us only.
So are other hospitals also doing that apart from Reliance? And how does do we do that? And if we don’t then only Reliance is that and other hospitals are doing that. How does that affect, you know, retaining doctor talent?
Ankit Thakker
So I don’t have specific case studies on different hospitals. But I’ll tell you my thought process, my thought process is that in the long term it is not sustainable to compensate people significantly above or significantly below industry standards. You have to be in line with the industry because you know significantly above naturally is inefficient significantly below. You risk continual attrition and inflation unstable teams. So you have to be fair in your compensation models. As far as we are concerned, we have a mix of some doctors who choose to exclusively practice with us. And we are also okay if we consider as respectable professionals some of them would want to come on a visiting basis as well.
But what we do endeavor and we have achieved is that all branches of medicine and will have someone exclusively working with the hospital so that if a patient shows up at our door at no point in time, we are in a position to not deliver on the Care. So we will have exclusive practitioners in all branches but we will not insist on only having exclusive practitioners.
Kaustav Bubna
Okay, great. Thank you so much. And if I could just squeeze in one more. How do you, I mean you see hospitals in South Bombay and all these known hospitals just across Bombay, they. A big selling point to get customers is to have the best known doctors perform surgeries and do consulting in their hospitals. So I mean since our locations are not, you know, the status quo patients in terms of accessibility from where those doctors live, like obviously Domiwali would be a little further away from let’s say where a very popular doctor lives who’s known to be the best in their field.
How does the company get those doctors, compensate those doctors or provide attractive opportunities in those type of doctors to come? And consultants operate at let’s say Thani Adongavili Hospital of Jupiter.
Kaustav Bubna
So the definition of popular is known amongst the people. So the question is which people? The doctors who you are defining as popular in South Bombay are unknown names in Coimbatore. You know, so medicine is a local and a hyper local service. You definitely need known and trustworthy doctors who are available in the region where you can seek care. There are extremely good doctors in MD Anderson and in Cleveland Clinic. But unfortunately South Bombay cannot access them. Does not mean South Bombay does not go to some other people who say they consider popular. So that is similar for all locations.
You know in the world that each micro market will have people who are more popular, more qualified and based on those locations people will choose where they want to seek care.
operator
Thank you. Mr. Bhuvana, please rejoin the queue for more questions. Next question comes from the line of Shashi Ranjan with Anandan Capital. Please go back.
Unidentified Participant
Good morning. Thank you for the opportunity. Sir, just for my enlightenment, can you help me understand? Do we cater to PMJ AY or Ayushman Bharat cases or extremely weaker section patients who come to us and in case we cater to them, are we getting paid by the government on time? Thank you.
Ankit Thakker
So as you must have seen from our report, we have just 1% of the revenue coming in from the government schemes. So in our view that is our social contribution. We only have government schemes for two branches. Radiation treatment for cancer and congenital heart diseases for children, pediatric heart problems. So these are the only two problems where we have. Government schemes. So it is not meaningful impact on our PNL and in any case in our mind it is a social contribution. So yeah, they don’t really impact us too much.
Unidentified Participant
Thank you sir.
Ankit Thakker
Thank you.
operator
Thank you. A Reminder to all the participants that you may press star and one to ask a question. Next question comes from the line of Amit Tawani with Clearbrew Capital. Please go ahead.
Amit Thawani
Thank you sir for taking my follow up. I was just, I wanted to pick your brain on what is the, what you believe is the long term RPOB growth.
Ankit Thakker
So I’ve just answered that in at length earlier. RPOB will grow in line with inflation for mature hospitals and faster for in the first few years. Once it reaches maturity, it will be in line with inflation. Thank you.
Amit Thawani
And just so when we renew with our insurers, what is the insurance renewal that we are taking from them?
Ankit Thakker
Inflation linked.
Amit Thawani
Which is 5. Is it, is it quantified in our contracts?
Ankit Thakker
It can’t be quantified in advance but at the time of each renewal it is negotiated.
Amit Thawani
Okay. At the time of renewal we are, we are negotiating based on how, what the prevailing inflation is.
Ankit Thakker
Correct.
Amit Thawani
Okay. And what is, is that Because I believe our costs could go higher than inflation. Like I mean cost of nurses and doctors could be higher than inflation. So how is, and our POB is also going to be linked to inflation. So how is that going to impact our margins?
Unidentified Participant
This is going to be a long answer, Amit. I think we should catch up separately.
Amit Thawani
If you can give it in a couple of lines or I’ll appreciate it. I mean, I just want to know if there is a long term impact on our margins.
Ankit Thakker
I don’t know. Let us see. Whatever happens to the industry will happen. How the macroeconomics will play out, how the wages will happen over the next several years. What will be the impact of trade and capex and consumables and GST over the next multiple years? How will taxation play out? You know, too much of astrology is difficult to do. I’m sorry but I really don’t have. Too many answers about this.
Amit Thawani
Thank you. Thank you sir. Appreciate it.
Ankit Thakker
Thank you.
Amit Thawani
But last, there is something called a common impandiment program. We don’t plan to join that, right?
Ankit Thakker
No, currently there is nothing discussed under discussion with Jupiter on common impairment.
Amit Thawani
Thank you. Thank you so much.
Ankit Thakker
Thank you.
operator
Thank you. Ladies and gentlemen. That was the last question for today. We have reached the end of question and answer session. I would now like to hand the conference over to the management for closing comments.
Ankit Thakker
Thank you everyone. I hope that I have answered the question satisfactorily. If anyone has more questions, please feel free to reach out to SGA and they’ll put you in touch with us. Thank you.
operator
Thank you. On behalf of Jupiter Lifeline Hospital, Limited. That concludes this conference. Thank you for joining us. You may now disconnect your lines.